VITAGLIANO, DONATA
 Distribuzione geografica
Continente #
NA - Nord America 267
EU - Europa 185
AS - Asia 104
AF - Africa 8
Totale 564
Nazione #
US - Stati Uniti d'America 261
SG - Singapore 47
DE - Germania 37
IT - Italia 37
UA - Ucraina 37
SE - Svezia 30
CN - Cina 26
HK - Hong Kong 24
FI - Finlandia 15
GB - Regno Unito 9
CI - Costa d'Avorio 8
IE - Irlanda 8
CA - Canada 6
FR - Francia 6
NL - Olanda 5
VN - Vietnam 4
IN - India 2
RU - Federazione Russa 1
TR - Turchia 1
Totale 564
Città #
Chandler 52
Jacksonville 40
Singapore 36
Hong Kong 24
Santa Clara 18
Millbury 15
Princeton 11
Woodbridge 8
Ashburn 7
Wilmington 7
Amsterdam 5
Beijing 5
Boston 5
Helsinki 5
Munich 5
Dong Ket 4
Kronberg 4
Nanjing 4
Nürnberg 4
Ottawa 4
Des Moines 3
Nanchang 3
Tianjin 3
Naples 2
Napoli 2
Redwood City 2
San Mateo 2
Toronto 2
Acerra 1
Augusta 1
Boardman 1
Cambridge 1
Casapulla 1
Caserta 1
Dearborn 1
Didim 1
Edinburgh 1
Formia 1
Fremont 1
Hangzhou 1
Hebei 1
Hicksville 1
Indiana 1
Kunming 1
La Canada Flintridge 1
Little Rock 1
Marigliano 1
Monmouth Junction 1
Moscow 1
Nanyang 1
Norwalk 1
Rome 1
Shanghai 1
Torino 1
Vitulazio 1
Totale 309
Nome #
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 78
Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia 77
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. 61
Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models 59
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 54
The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells. 53
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases 48
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas 44
The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells 43
ONYX-015, an E1B gene-defective adenovirus,induces cell death in human anaplastic thyroid carcinoma cell lines. 42
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells. 34
Totale 593
Categoria #
all - tutte 2.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 3 3 0 6 5 8
2020/2021101 0 8 15 8 9 18 9 0 11 3 15 5
2021/202269 4 0 0 1 1 3 0 1 8 8 14 29
2022/2023105 13 14 8 6 10 11 0 13 20 4 5 1
2023/202455 2 9 5 4 2 3 0 12 0 0 16 2
2024/2025106 12 34 4 1 7 22 26 0 0 0 0 0
Totale 593